This inventor holds 5 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Novartis Vaccines & Diagnostics, Gmbh. Active years: 2007-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2012
Title: Lorianne K Masuoka: Innovator in B-cell Malignancies Treatment
Introduction
Lorianne K Masuoka is a notable inventor based in Oakland, California, recognized for his contributions to the medical field, particularly in the treatment of B-cell malignancies. With a portfolio that includes five patents, Masuoka is dedicated to developing innovative therapeutic methods that enhance patient care.
Latest Patents
Among his most recent patents are methods of therapy for B-cell malignancies utilizing antagonist anti-CD40 antibodies. These methods involve administering a therapeutically effective amount of an antagonist anti-CD40 antibody or its antigen-binding fragment to patients suffering from B-cell related cancers. The technology innovatively distinguishes between malignant and normal human B cells, ensuring that the antibody exhibits antagonist activity specifically against the malignant cells. This precision not only inhibits the proliferation and differentiation of these harmful cells but also upholds the integrity of normal B cells by being free of significant agonist activity.
Career Highlights
Lorianne K Masuoka’s career is emblematic of dedication to research and development in immunotherapy. His work at Novartis Vaccines & Diagnostics, Gmbh highlights his involvement in pioneering biotech solutions aimed at treating complex health conditions. His expertise in targeting B-cell malignancies demonstrates a significant commitment to advancing therapeutic options in oncology.
Collaborations
Masuoka collaborates closely with Keting Chu, with whom he shares a commitment to harnessing scientific knowledge for progressive healthcare solutions. Their collaborative efforts illustrate a synergy that fosters innovation and propels research toward viable treatments.
Conclusion
Lorianne K Masuoka's inventive spirit, coupled with his scientific acumen, positions him as a leading figure in the realm of therapeutic development for B-cell malignancies. His patents reflect a profound understanding of the mechanisms at play in cancer treatment, paving the way for future advancements in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile